The panel discusses soft tissue sarcomas, emphasising health economics and patient outcomes. It addresses financial and time toxicity affecting quality of life, particularly in India, where health economics challenges are significant. A session on ecancermedicalscience is highlighted, focusing on its support for authors and academicians from low and middle-income countries, showcasing its importance in the field.